Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

ClinicalTrials.gov ID: NCT00261846

Public ClinicalTrials.gov record NCT00261846. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2 Study Of Bosutinib (Ski-606) In Philadelphia Chromosome Positive Leukemias

Study identification

NCT ID
NCT00261846
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
571 participants

Conditions and interventions

Interventions

  • Bosutinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 17, 2006
Primary completion
Sep 24, 2009
Completion
Aug 5, 2015
Last update posted
Jul 26, 2017

2006 – 2015

United States locations

U.S. sites
29
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
City of Hope National Medical Center Duarte California 91010
HealthONE Presbyterian Denver Colorado 80218
Rocky Mountain Cancer Centers Denver Colorado 80218
Georgetown University Hospital Washington D.C. District of Columbia 20007
Emory Clinic Atlanta Georgia 30322
Emory University Hospital Atlanta Georgia 30322
Winship Cancer Institute Atlanta Georgia 30322
Oncology Specialists, S.C. Niles Illinois 60714
Indiana Blood and Marrow Transplantation Indianapolis Indiana 46237
LSU Health Sciences Center Shreveport Louisiana 71103
University Of Maryland Medical Center Baltimore Maryland 21201
University Of Maryland Baltimore Maryland 21201
Roswell Park Cancer Institute Buffalo New York 14263
Hudson Valley Hematology and Oncology Associates Hawthorne New York 10532
Westchester Oncology Hematology Group, P.C. Hawthorne New York 10532
Westchester Oncology Hematology, Group, P.C. Hawthorne New York 10532
New York Presbyterian Hospital New York New York 10021
New York Presbyterian Hospital New York New York 10065
University of Rochester Cancer Center Pharmacy Rochester New York 14642
University of Rochester Medical Center Strong Memorial Hospital - James P. Wilmot Cancer Center Rochester New York 14642
University of Rochester Medical Center Rochester New York 14642
University of Rochester-James P. Wilmot Cancer Center Rochester New York 14642
University of Rochester Rochester New York 14642
Westchester Medical Center Valhalla New York 10595
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033-0850
MD Anderson Cancer Center Houston Texas 77030-4009
The University of Texas MD Anderson Cancer Center Houston Texas 77030
The University of Texas Houston Texas 77030
Virginia Commonwealth University Richmond Virginia 23298-0157

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00261846, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2017 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00261846 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →